Cancer-related pain
Exploring drug-delivery approaches relevant to the management of cancer-related pain.
Learn morePlatform technology
NanoCelle™Advancing the science of drug delivery.
NanoCelle™ is Medhealth Clinical’s patented sub-micron delivery platform, developed to improve how active ingredients are formulated, delivered and absorbed.
The challenge
Getting the medicine there is only part of the solution.
A molecule's potential depends not only on what it is, but also on how it is delivered.
Drug-delivery science addresses challenges including absorption, consistency, administration and the practical demands of long-term treatment.
Drug-delivery science addresses challenges including absorption, consistency, administration and the practical demands of long-term treatment.
Absorption
Improving how medicines are delivered.
Consistency
More predictable delivery.
Onset
Delivering when it matters.
Administration
Simpler ways to deliver medicine.
Adherence
Designed with patients in mind.
Formulation
Rethinking conventional delivery.
What is NanoCelle
A platform engineered at the sub-micron scale.
NanoCelle™ is designed to disperse active ingredients into sub-micron particles for oro-mucosal delivery.
The platform brings together particle-size engineering, formulation science and delivery design to explore new ways of presenting medicines to the body.
- Sub-micron
- Oro-mucosal
- NanoCelle™
- Patented
Platform story
Four stages connect the platform to the application.
- 01
Medicine
An active pharmaceutical ingredient selected for a defined research objective.
- 02
NanoCelle™
The active ingredient is formulated using the platform to create a fine sub-micron dispersion.
- 03
Delivery & absorption
The formulation is designed to present the active ingredient across mucosal tissue and support absorption.
- 04
Therapeutic development
Promising opportunities can progress through structured research and development programs.
From science to application
Turning formulation science into development opportunities.
NanoCelle™ is evaluated molecule by molecule, with formulation, delivery and absorption considered in the context of each potential application.
How it works
A closer look at the platform.
01
Formulation
Active ingredients are formulated to create a stable sub-micron dispersion.
- Sub-micron particle engineering
- Stability and consistency testing
- Dose-form development
Particle engineering
Optimising particle size and dispersion.
Stability
Evaluating consistency across formulation and storage.
Dose-form development
Exploring practical delivery formats.
Scientific principles
The science behind NanoCelle™.
Particle size
Smaller particles can provide greater effective surface area for interaction with biological tissue.
Dispersion
A consistent formulation is central to reproducible delivery.
Route
Oro-mucosal administration provides an alternative route for suitable molecules.
Molecule-specific performance
Delivery behaviour is evaluated for each molecule and application.
Designed for possibility
What NanoCelle™ is designed to enable.
01
Sub-micron particle engineering
Designed to create fine dispersions of active ingredients.
02
Oro-mucosal delivery
Designed around a non-invasive route of administration.
03
Formulation flexibility
Being explored across different molecule classes and applications.
04
Practical dose forms
Designed with usability and delivery considerations in mind.
Applications
Exploring where the platform can go.
Medhealth Clinical is exploring the potential of NanoCelle™ across selected therapeutic areas and development opportunities.
Chronic conditions
Investigating delivery formats for therapies where consistency and practical administration are important.
Learn moreNeurological applications
Exploring whether sub-micron delivery may offer opportunities across selected neurological applications.
Learn moreEmerging opportunities
Assessing additional applications where the platform and formulation approach may be scientifically appropriate.
Learn moreResearch
Science supporting the platform.
Research into NanoCelle™ spans formulation, delivery, preclinical investigation and therapeutic development.
Patents & intellectual property
Protected technology. Built for innovation.
NanoCelle™ is a patented drug-delivery platform developed by Medhealth Clinical.
Development programs
From platform to therapeutic opportunity.
NanoCelle™ provides the foundation for selected research and development programs across therapeutic areas.
Partnerships
Partnering to advance drug delivery.
We work with pharmaceutical and biotechnology organisations, research institutions and clinical investigators on research collaborations, co-development and licensing where the science supports it.